This topic contains a solution. Click here to go to the answer

Author Question: A client who has been authorized to participate in the home-delivered meals program will receive at ... (Read 23 times)

dejastew

  • Hero Member
  • *****
  • Posts: 562
A client who has been authorized to participate in the home-delivered meals program will receive at least:
 
  a. one nutritious meal every day of the week.
  b. two nutritious meals every day of the week.
  c. one nutritious meal 5 days a week.
  d. two nutritious meals 5 days a week.

Question 2

The eligibility requirement that must be met to participate in a congregate meals program or a home-delivered meals program is:
 
  a. living alone.
  b. 60 years of age or older.
  c. diagnosed health problem or disability.
  d. income below the federal poverty level.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

milbourne11

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

C

Answer to Question 2

B




dejastew

  • Member
  • Posts: 562
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


6ana001

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library